Islam, RashidulRashidulIslamHeyer, JannisJannisHeyerFigura, MiriamMiriamFiguraWang, XiaoyanXiaoyanWangNie, XichenXichenNieNathaniel, BenedictBenedictNathanielIndumathy, SivanjahSivanjahIndumathyHartmann, KatjaKatjaHartmannPleuger, ChristianeChristianePleugerFijak, MonikaMonikaFijakKliesch, SabineSabineKlieschDittmar, FlorianFlorianDittmarPilatz, AdrianAdrianPilatzWagenlehner, FlorianFlorianWagenlehnerHedger, MarkMarkHedgerLoveland, BruceBruceLovelandHotaling, James H.James H.HotalingGuo, JingtaoJingtaoGuoLoveland, Kate L.Kate L.LovelandSchuppe, Hans-ChristianHans-ChristianSchuppeFietz, DanielaDanielaFietz2024-12-112024-12-112024https://jlupub.ub.uni-giessen.de/handle/jlupub/20024https://doi.org/10.22029/jlupub-19379Background: Immune cell infiltration is heterogeneous but common in testicular germ cell tumors (TGCT) and pre-invasive germ cell neoplasia in situ (GCNIS). Tumor-infiltrating T cells including regulatory T (Treg) and follicular helper T (Tfh) cells are found in other cancer entities, but their contributions to TGCT are unknown. Methods: Human testis specimens from independent patient cohorts were analyzed using immunohistochemistry, flow cytometry and single-cell RNA sequencing (scRNA-seq) with special emphasis on delineating T cell subtypes. Results: Profound changes in immune cell composition within TGCT, shifting from macrophages in normal testes to T cells plus B and dendritic cells in TGCT, were documented. In most samples (96%), the CD4+ T cell frequency exceeded that of CD8+ cells, with decreasing numbers from central to peripheral tumor areas, and to tumor-free, contralateral testes. T cells including Treg and Tfh were most abundant in seminoma compared to mixed tumors and embryonal carcinoma. Conclusion: Despite considerable heterogeneity between patients, T cell subtypes form a key part of the TGCT microenvironment. The novel finding of rare Treg and Tfh cells in human testis suggests their involvement in TGCT pathobiology, with implications for understanding tumor progression, to assess patients’ prognosis, and as putative targets for personalized immunotherapy.enNamensnennung 4.0 Internationalddc:630